Retinoic acid suppresses growth of lesions, inhibits peritoneal cytokine secretion, and promotes macrophage differentiation in an immunocompetent mouse.

Slides:



Advertisements
Similar presentations
Therapeutic Effect of Angiostatin Gene Transfer in a Murine Model of Endometriosis  Charlotta Dabrosin, Steve Gyorffy, Peter Margetts, Catherine Ross,
Advertisements

Nonsteroidal antiinflammatory drugs differentially suppress endometriosis in a murine model  Jason A. Efstathiou, M.D., David A. Sampson, B.A., Zalman.
David Langoi, D. V. M. , Mary Ellen Pavone, M. D. , M. S. C. I
Selective cyclo-oxygenase-2 inhibition induces regression of autologous endometrial grafts by down-regulation of vascular endothelial growth factor-mediated.
Immune-inflammation gene signatures in endometriosis patients
Effects of hyperprolactinemia treatment with the dopamine agonist quinagolide on endometriotic lesions in patients with endometriosis-associated hyperprolactinemia 
Surgical removal of endometriotic lesions alters local and systemic proinflammatory cytokines in endometriosis patients  Stephany P. Monsanto, M.Sc.,
Upregulation of Inflammatory Cytokines and Oncogenic Signal Pathways Preceding Tumor Formation in a Murine Model of T-Cell Lymphoma in Skin  Xuesong Wu,
Dietary fish oil supplementation inhibits formation of endometriosis-associated adhesions in a chimeric mouse model  Jennifer L. Herington, Ph.D., Dana.
Evaluation of the antiproliferative, proapoptotic, and antiangiogenic effects of a double- stranded RNA mimic complexed with polycations in an experimental.
Contribution of different bone marrow-derived cell types in endometrial regeneration using an irradiated murine model  Claudia Gil-Sanchis, Ph.D., Irene.
Expression of cyclooxygenase-2 and vascular endothelial growth factor in ovarian endometriotic cysts and their relationship with angiogenesis  Seyit Temel.
Endometriosis-associated nerve fibers, peritoneal fluid cytokine concentrations, and pain in endometriotic lesions from different locations  Brett McKinnon,
Regeneration of spermatogenesis by grafting testicular tissue or injecting testicular cells into the testes of sterile mice: a comparative study  Dorien.
Volume 9, Issue 3, Pages (March 2004)
Sébastien Colette, Ph. D. , Sylvie Defrère, Ph. D
Patrick Kibangou Bondza, Ph. D. , Christine N. Metz, Ph. D
Lipiodol alters murine uterine dendritic cell populations: A potential mechanism for the fertility-enhancing effect of lipiodol  Neil Phillip Johnson,
Dorien Van Saen, Ph. D. , Ellen Goossens, Ph. D. , Joeri L. Aerts, Ph
Stromal cells from endometriotic lesions and endometrium from women with endometriosis have reduced decidualization capacity  Petra A.B. Klemmt, D.Phil.,
Volume 17, Issue 2, Pages (February 2009)
Christian M. Becker, M. D. , David A. Sampson, B. A. , Maria A
Volume 18, Issue 10, Pages (October 2010)
Khaleque Newaz Khan, M. D. , Ph. D. , Michio Kitajima, M. D
Regine Gaetje, M. D. , Uwe Holtrich, Ph. D. , Thomas Karn, Ph. D
Michio Kitajima, M. D. , Ph. D. , Sylvie Defrère, Ph. D
Carla Olivares, M. Sc. , Analía Ricci, M. Sc. , Mariela Bilotas, Ph. D
Change of proinflammatory cytokines follows certain patterns after induction of endometriosis in a mouse model  Qiong-Hua Chen, Ph.D., Wei-Dong Zhou,
Aberrant gene expression profile in a mouse model of endometriosis mirrors that observed in women  Katherine E. Pelch, B.S., Amy L. Schroder, B.S., Paul.
Fertility and Sterility
Peritoneal fluid macrophages in endometriosis: correlation between the expression of estrogen receptors and inflammation  Paola Montagna, B.Sc., Silvia.
Nonsteroidal antiinflammatory drugs differentially suppress endometriosis in a murine model  Jason A. Efstathiou, M.D., David A. Sampson, B.A., Zalman.
A tissue-engineered human endometrial stroma that responds to cues for secretory differentiation, decidualization, and menstruation  Stacey C. Schutte,
A potential role for colony-stimulating factor 1 in the genesis of the early endometriotic lesion  Jani R. Jensen, M.D., Craig A. Witz, M.D., Robert S.
Elizabeth Taylor, M.D., Christina Williams, M.D. 
Sana M. Salih, M. D. , Salama A. Salama, Ph. D. , Amin A. Fadl, Ph. D
Dioxin may promote inflammation-related development of endometriosis
Effect of aromatase inhibitors on ectopic endometrial growth and peritoneal environment in a mouse model of endometriosis  Mariela Bilotas, Ph.D., Gabriela.
Imatinib decreases endometrial stromal cell transmesothial migration and proliferation in the extracellular matrix of modeled peritoneum  Jason S. Griffith,
Uterine adenomyoma presenting as a vesico-uterine endometrioma
Both host and graft vessels contribute to revascularization of xenografted human ovarian tissue in a murine model  Anne-Sophie Van Eyck, M.D., Caroline.
Induction of peritoneal endometriosis in nude mice with use of human immortalized endometriosis epithelial and stromal cells: a potential experimental.
Kaylon L. Bruner-Tran, Ph. D. , Alessandra C. Carvalho-Macedo, M. D
Endometrial reconstruction from stem cells
Effect of pentoxifylline on vascular endothelial growth factor C and flk-1 expression on endometrial implants in the rat endometriosis model  Nikos F.
Tamir S. Aldad, B. A. , Nora Rahmani, B. A. , Csaba Leranth, Ph. D
Edurne Novella-Maestre, Ph. D. , Sonia Herraiz, Ph. D
Parthenolide reduces cell proliferation and prostaglandin estradiol synthesis in human endometriotic stromal cells and inhibits development of endometriosis.
Murat Ulukus, M. D. , E. Cagnur Ulukus, M. D. , Ege N
Evaluation of the potential therapeutic effects of a double-stranded RNA mimic complexed with polycations in an experimental mouse model of endometriosis 
Fms-like tyrosine kinase 3 ligand increases a lung DC subset with regulatory properties in allergic airway inflammation  Zhifei Shao, MD, Arpita S. Bharadwaj,
Progression of conservatively treated endometrial complex atypical hyperplasia in a young woman: a case report  Giacomo Corrado, M.D., Ph.D., Ermelinda.
Granulocyte colony-stimulating factor in conjunction with vascular endothelial growth factor maintains primordial follicle numbers in transplanted mouse.
Qiong-Hua Chen, Ph. D. , Wei-Dong Zhou, Ph. D. , De-Min Pu, M. D
Fertility and Sterility
Toward gene therapy of endometriosis: adenovirus-mediated delivery of dominant negative estrogen receptor genes inhibits cell proliferation, reduces cytokine.
Interleukin-1 system messenger ribonucleic acid and protein expression in human fallopian tube may be associated with ectopic pregnancy  Hong-Yuan Huang,
Effectiveness of photodynamic ablation for destruction of endometrial explants in a rat endometriosis model  Alicja A Krzemien, M.D., Dean A Van Vugt,
The presence of endometrial cells in the peritoneal cavity enhances monocyte recruitment and induces inflammatory cytokines in mice: Implications for.
Sorafenib inhibits growth, migration, and angiogenic potential of ectopic endometrial mesenchymal stem cells derived from patients with endometriosis 
Endometriotic haptoglobin binds to peritoneal macrophages and alters their function in women with endometriosis  Kathy L Sharpe-Timms, Ph.D., Randy L.
Intestinal endometriosis complicated by ileal perforation after initiation of gonadotropin- releasing hormone agonist therapy  Sayaka Saito, M.D., Takashi.
Pharmacologic therapies in endometriosis: a systematic review
Fertility and Sterility
Nerve fibers and menstrual cycle in peritoneal endometriosis
Soluble HLA-G in the peritoneal fluid of women with endometriosis
A selective cyclooxygenase-2 inhibitor suppresses the growth of endometriosis with an antiangiogenic effect in a rat model  Daniel Escorsim Machado, M.Sc.,
Tina Khanam, B.Sc., Geoffrey Burnstock, Ph.D., D.Sc. 
Endometrial polyps affect uterine receptivity
Immunobiology of endometriosis
Presentation transcript:

Retinoic acid suppresses growth of lesions, inhibits peritoneal cytokine secretion, and promotes macrophage differentiation in an immunocompetent mouse model of endometriosis  Friedrich Wieser, M.D., Juanjuan Wu, M.D., Ph.D., Zhaoju Shen, Ph.D., Robert N. Taylor, M.D., Ph.D., Neil Sidell, Ph.D.  Fertility and Sterility  Volume 97, Issue 6, Pages 1430-1437 (June 2012) DOI: 10.1016/j.fertnstert.2012.03.004 Copyright © 2012 American Society for Reproductive Medicine Terms and Conditions

Figure 1 Endometriotic lesions in recipient mice, 14 days after inoculation. (A) Green fluorescent protein transgenic (GFP+) lesions were visible in situ using interference filter eyeglasses (excitation wavelength, 488 nm; emission wavelength, 502 nm). (B) The view at a higher power (×5.6) shows large cystic and two small satellite GFP+ lesions invading anterior parietal peritoneum and preperitoneal fat in the left lower pelvis. (C) A high-magnification (×12) view of GFP+ lesion shows the vascular arcade of an established GFP+ implant (arrow indicating vessel branch point). Pictures were taken with a Hamamatsu Multiplier CCD Camera. (D) Hematoxylin and eosin histology of murine endometriotic lesions was nearly identical to that observed in the human counterpart. This example of a cystic lesion was lined by dense epithelium and surrounded by endometrial stroma. The lesion invaded subperitoneal fat (SPF) and subperitoneal muscle (SPM). The cyst wall contained blood vessels (BV), and the cyst contents included erythrocytes (pink) and leukocytes (purple). Magnification: ×40. Fertility and Sterility 2012 97, 1430-1437DOI: (10.1016/j.fertnstert.2012.03.004) Copyright © 2012 American Society for Reproductive Medicine Terms and Conditions

Figure 2 Inhibition of lesion growth by all-trans-retinoic acid (RA). The RA or vehicle control treatment began 3 days before intraperitoneal inoculation of endometrial cells and continued for 14 days until the mice were killed. The RA treatment statistically significantly reduced the mean number of total lesions and number of vascularized lesions versus vehicle-treated controls (n = 22 for both groups). In addition, the average volume of established endometriotic lesions in the RA group was statistically significantly less than those in the control group. Values represent the mean ± standard error of the mean of the indicated lesion count parameter. ∗Statistically significant decrease of the indicated lesion parameter compared with control-treated mice (P<.03). Fertility and Sterility 2012 97, 1430-1437DOI: (10.1016/j.fertnstert.2012.03.004) Copyright © 2012 American Society for Reproductive Medicine Terms and Conditions

Figure 3 Suppressive effects of all-trans-retinoic acid (RA) treatment on peritoneal fluid interleukin-6 (IL-6) and macrophage chemotactic factor-1 (MCP-1) levels. Values represent the mean ± standard error of the mean of cytokine levels found in control and RA-treated animals 3 days (n = 10, both groups) and 14 days (n = 22, both groups) after induction of endometriosis. (−) indicates below the level of detection. ∗Statistically significant decrease in levels of the indicated cytokine compared with control-treated mice (P<.05) ^Statistically significant reduction in 14-day control and RA-treated samples compared with those from correspondingly treated groups at day 3 (P<.01). Fertility and Sterility 2012 97, 1430-1437DOI: (10.1016/j.fertnstert.2012.03.004) Copyright © 2012 American Society for Reproductive Medicine Terms and Conditions

Figure 4 (A) Representative dot plot showing CD11b and F4/80 fluorescent intensity of peritoneal cells from a control mouse 14 days after induction of endometriosis. Subpopulations of viable eosinophils (E, CD11bmediumF4/80medium), neutrophils (N, CD11bmediumF4/80negative), and macrophages (M, CD11bhighF4/80high) are indicated. Dot blot analysis of mice treated with all-trans-retinoic acid (RA) showed similar population profiles. (B) Cells gated on the macrophage (M) population were analyzed for CD11b, F4/80, and CD38 expression. Up-regulation by RA of the macrophage markers (CD11b and F4/80) and the differentiation/activation marker CD38 was observed. Values represent the mean fluorescence intensity ± standard error of the mean of the surface proteins as indicated in control (n = 22) and RA-treated (n = 22) mice. ∗P<.03. ∗∗P<.002. Fertility and Sterility 2012 97, 1430-1437DOI: (10.1016/j.fertnstert.2012.03.004) Copyright © 2012 American Society for Reproductive Medicine Terms and Conditions